日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diverse actions of 15 structurally unrelated mitochondrial uncouplers in cells and mice

15种结构不相关的线粒体解偶联剂在细胞和小鼠中的不同作用

Shah, Divya P; Vancuylenburg, Calum S; Olzomer, Ellen M; Chen, Sing-Young; Grams, Robert J; Beretta, Martina; Byrne, Frances L; Santos, Webster L; Hoehn, Kyle L

Liver-Selective Imidazolopyrazine Mitochondrial Uncoupler SHD865 Reverses Adiposity and Glucose Intolerance in Mice

肝脏选择性咪唑并吡嗪类线粒体解偶联剂SHD865可逆转小鼠的肥胖和葡萄糖耐受不良

Beretta, Martina; Dai, Yumin; Olzomer, Ellen M; Vancuylenburg, Calum S; Santiago-Rivera, José A; Philp, Ashleigh M; Hargett, Stefan R; Li, Keyong; Shah, Divya P; Chen, Sing-Young; Alexopoulos, Stephanie J; Li, Catherine; Harris, Thurl E; Lee, Brendan; Wathier, Michel; Cermak, Jennifer M; Tucker, Simon P; Turner, Nigel; Bayliss, Douglas A; Philp, Andrew; Byrne, Frances L; Santos, Webster L; Hoehn, Kyle L

Design, Synthesis, and Biological Evaluation of [1,2,5]Oxadiazolo[3,4-b]pyridin-7-ol as Mitochondrial Uncouplers for the Treatment of Obesity and Metabolic Dysfunction-Associated Steatohepatitis.

[1,2,5]恶二唑并[3,4-b]吡啶-7-醇作为线粒体解偶联剂治疗肥胖和代谢功能障碍相关脂肪性肝炎的设计、合成和生物学评价

Foutz Mary A, Krinos Emily L, Beretta Martina, Hargett Stefan R, Shrestha Riya, Murray Jacob H, Duerre Ethan, Salamoun Joseph M, McCarter Katrina, Shah Divya P, Hoehn Kyle L, Santos Webster L

Clinical profile and treatment outcomes of drug-resistant tuberculosis before directly observed treatment strategy plus: Lessons for the program

直接观察治疗策略实施前耐药结核病的临床特征和治疗结果:对该方案的启示

Dholakia, Yatin N; Shah, Divya P